<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://therapeutica.es/ciencia/contraste-hierro-resonancia-fibrosis-cardiaca-cic-biomagune/</loc>
    <news:news>
      <news:publication>
        <news:name>Therapeutica</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T15:31:01.204Z</news:publication_date>
      <news:title>Un contraste de hierro marca la fibrosis cardiaca en tejido humano de laboratorio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://therapeutica.es/salud/eeuu-peptidos-sin-aprobar-fda-politica-hhs/</loc>
    <news:news>
      <news:publication>
        <news:name>Therapeutica</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T10:17:10.095Z</news:publication_date>
      <news:title>EE UU abre la puerta a péptidos sin aprobar pese al rechazo de técnicos de la FDA</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://therapeutica.es/salud/oms-emergencia-salud-publica-cambio-climatico-peticion-investigadores/</loc>
    <news:news>
      <news:publication>
        <news:name>Therapeutica</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T10:17:07.025Z</news:publication_date>
      <news:title>Investigadores piden a la OMS declarar el clima emergencia sanitaria internacional</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://therapeutica.es/salud/revision-anual-pago-bolsillo-pensilvania-prevention-science/</loc>
    <news:news>
      <news:publication>
        <news:name>Therapeutica</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T10:17:05.024Z</news:publication_date>
      <news:title>Uno de cada cuatro asegurados en Pensilvania pagó por su revisión anual</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://therapeutica.es/salud/discriminacion-cancer-revision-psycho-oncology-flinders/</loc>
    <news:news>
      <news:publication>
        <news:name>Therapeutica</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T12:22:08.647Z</news:publication_date>
      <news:title>Tras el cáncer, otra barrera: empleo, seguros y estigma en más de 100 estudios</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://therapeutica.es/ciencia/lsd-psilocibina-flujo-sanguineo-cerebral-estudio-copenhague/</loc>
    <news:news>
      <news:publication>
        <news:name>Therapeutica</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T12:22:07.339Z</news:publication_date>
      <news:title>LSD y psilocibina mueven el flujo sanguíneo cerebral en sentidos opuestos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://therapeutica.es/ciencia/neuronas-inmaduras-resiliencia-cognitiva-alzheimer-holanda/</loc>
    <news:news>
      <news:publication>
        <news:name>Therapeutica</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T12:22:02.221Z</news:publication_date>
      <news:title>Por qué algunos cerebros con lesiones de alzhéimer no desarrollan demencia</news:title>
    </news:news>
  </url>
</urlset>